ATP13A2/PARK9 regulates secretion of exosomes and α-Synuclein

Journal of Neuroscience

Volumn 34, Issue 46, 2014, Pages 15281-15287

  Tsunemi, Taiji ^a   Hamada, Kana ^a   Krainc, Dimitri ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ATP13A2; Exosome; Multivesicular body; PARK9; Parkinson s disease; synuclein

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA SYNUCLEIN; ATP13A2; ESCRT PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; ATP13A2 PROTEIN, HUMAN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BIOGENESIS; CELL ISOLATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; EXTRACELLULAR SPACE; FIBROBLAST CULTURE; GENE FUNCTION; GENE OVEREXPRESSION; H4 CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOGOLD ELECTRON MICROSCOPY; MOUSE; MULTIVESICULAR BODY; NONHUMAN; PARKINSON DISEASE; PLASMID; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BRAIN CORTEX; CELL LINE; GENETICS; MALE; METABOLISM; MUTATION; NERVE CELL; PARKINSONISM; PHYSIOLOGY; PRIMARY CELL CULTURE; SECRETION (PROCESS);

ALPHA-SYNUCLEIN; ANIMALS; CELL LINE; CEREBRAL CORTEX; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; EXOSOMES; HUMANS; MALE; MICE; MUTATION; NEURONS; PARKINSONIAN DISORDERS; PRIMARY CELL CULTURE; PROTON-TRANSLOCATING ATPASES;

EID: 84909952796     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1629-14.2014     Document Type: Article

References (49)

1. Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, Cooper JM (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 42:360–367.CrossRef Medline
2. Angot E, Steiner JA, Hansen C, Li JY, Brundin P (2010) Are synucleinopathies prion-like disorders? Lancet Neurol 9:1128–1138.CrossRef Medline
3. Axelsen KB, Palmgren MG (1998) Evolution of substrate specificities in the P-type ATPase superfamily. J Mol Evol 46:84–101. CrossRef Medline
4. Bache KG, Brech A, Mehlum A, Stenmark H (2003) Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J Cell Biol 162:435–442. CrossRef Medline
5. Colombo M, Moita C, van Niel G, Kowal J, Vigneron J, Benaroch P, Manel N, Moita LF, The´ry C, Raposo G (2013) Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci 126:5553–5565. CrossRef Medline
6. Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L, Vanderburg CR, McLean PJ (2012) Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 7:42. CrossRef Medline
7. Dehay B, Ramirez A, Martinez- Vicente M, Perier C, Canron MH, Doudnikoff E, Vital A, Vila M, Klein C, Bezard E (2012) Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc Natl Acad Sci U S A 109:9611–9616. CrossRef Medline
8. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 106:13010–13015. CrossRef Medline
9. El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MJ, Curran MD, Court JA, Mann DM, Ikeda S, Cookson MR, Hardy J., Allsop D (2003) α-Synuclein implicated in Parkinson’s disease is present in extracellular biological fluids, including human plasma. FASEB J 17: 1945–1947. CrossRef Medline
10. Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, Stefanis L, VekrellisK (2010) Cell-producedα-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30:6838–6851. CrossRef Medline
11. Falguieres T, Luyet PP, Bissig C, Scott CC, Velluz MC, Gruenberg J (2008) In vitro budding of intralumenal vesicles into late endosomes is regulated by Alix and Tsg101. Mol Biol Cell 19:4942–4955. CrossRef Medline
12. Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, Hill KJ, Caldwell KA, Caldwell GA, Cooper AA, Rochet JC, Lindquist S (2009) Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 41: 308–315. CrossRef Medline
13. Grunewald A, Arns B, Seibler P, Rakovic A, Munchau A, Ramirez A, Sue CM, Klein C (2012) ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor–Rakeb syndrome. Neurobiol Aging 33:18431–18437. CrossRef Medline
14. Gusdon AM, Zhu J, Van Houten B, Chu CT (2012) ATP13A2 regulates mitochondrial bioenergetics through macroautophagy. Neurobiol Dis 45:962–972. CrossRef Medline
15. Jakes R, Spillantini MG, Goedert M (1994) Identification of two distinct synucleins from human brain. FEBS Lett 345:27–32. CrossRef Medline
16. Jouvenet N. (2012) Dynamics of ESCRT proteins. Cell Mol Life Sci 69:4121–4133. CrossRef Medline
17. Kim BY, Olzmann JA, Barsh GS, Chin LS, Li L (2007) Spongiform neurodegeneration-associated E3 ligase Mahogunin ubiquitylates TSG101 and regulates endosomal trafficking. Mol Biol Cell 18:1129–1142. CrossRef Medline
18. Kobayashi T, Stang E, Fang KS, de Moerloose P, Parton RG, Gruenberg J (1998) A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature 392:193–197. CrossRefMedline
19. Kobayashi T, Vischer UM, Rosnoblet C, Lebrand C, Lindsay M, Parton RG, Kruithof EK, Gruenberg J (2000) The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol Biol Cell 11:1829–1843. CrossRef Medline
20. Kong SM, Chan BK, Park JS, Hill KJ, Aitken JB, Cottle L, Farghaian H, Cole AR, Lay PA, Sue CM, Cooper AA (2014) Parkinson’s disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes. Hum Mol Genet 23:2816–2833. CrossRef Medline
21. Lai CP, Breakefield XO (2012) Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Front Physiol 3:228. CrossRef Medline
22. Lee HJ, Patel S, Lee SJ (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25:6016–6024. CrossRef Medline
23. Ludwig AK, Giebel B (2012) Exosomes: small vesicles participating in intercellular communication. Int J Biochem Cell Biol 44:11–15. CrossRef Medline
24. Luk KC, Kehm V, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, Lee VM (2012) Pathological alpha-synuclein transmission initiates Parkinsonlike neurodegeneration in nontransgenic mice. Science 338:949–953. CrossRef Medline
25. Mane SM, Marzella L, Bainton DF, Holt VK, Cha Y, Hildreth JE, August JT (1989) Purification and characterization of human lysosomal membrane glycoproteins. Arch Biochem Biophys 268:360–378. CrossRef Medline
26. Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, Sidransky E, Grabowski GA, Krainc D (2011) Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146:37–52. CrossRef Medline
27. Najim al-Din AS, Wriekat A, Mubaidin A, Dasouki M, Hiari M (1994) Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor–Rakeb syndrome. Acta Neurol Scand 89:347–352. Medline
28. Olanow CW, Brundin P (2013) Parkinson’s disease and alpha synuclein: is Parkinson’s disease a prion-like disorder? Mov Disord 28:31–40. CrossRef Medline
29. Park JS, Mehta P, Cooper AA, Veivers D, Heimbach A, Stiller B, Kubisch C, Fung VS, Krainc D, Mackay- Sim A, Sue CM. (2011) Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor–Rakeb syndrome, a form of early-onset parkinsonism. Hum Mutat 32: 956–964. CrossRef Medline
30. Park JS, Koentjoro B, Veivers D, Mackay- Sim A, Sue CM. (2014) Parkinson’s disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction. Hum Mol Genet 23: 2802–2815. CrossRef Medline
31. Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, Simons K (2006) Alzheimer’s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A 103:11172–11177. CrossRef Medline
32. Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid LP, Goebel I, Mubaidin AF, Wriekat AL, Roeper J, Al- Din A, Hillmer AM, Karsak M, Liss B, Woods CG, Behrens MI, Kubisch C. (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38:1184–1191. CrossRef Medline
33. Ramonet D, Podhajska A, Stafa K, Sonnay S, Trancikova A, Tsika E, Pletnikova O, Troncoso JC, Glauser L, Moore DJ (2012) PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Hum Mol Genet 21:1725–1743. CrossRef Medline
34. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ (1996) B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183:1161–1172. CrossRef Medline
35. Saman S, Kim W, Raya M, Visnick Y, Miro S, Jackson B, McKee AC, Alvarez VE, Lee NC, Hall GF (2012) Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem 287:3842–3849. CrossRef Medline
36. Short JR, Knox C, Dorrington RA (2010) Subcellular localization and live-cell imaging of the Helicoverpa armigera stunt virus replicase in mammalian and Spodoptera frugiperda cells. J Gen Virol 91:1514–1523. CrossRef Medline
37. Schultheis PJ, Fleming SM, Clippinger AK, Lewis J, Tsunemi T, Giasson B, Dickson DW, Mazzulli JR, Bardgett ME, Haik KL, Ekhator O, Chava AK, Howard J, Gannon M, Hoffman E, Chen Y, Prasad V, Linn SC, Tamargo RJ, Westbroek W, et al. (2013) Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited alpha-synuclein accumulation and agedependent sensorimotor deficits. Hum Mol Genet 22:2067–2082. CrossRef Medline
38. Simons M, Raposo G (2009) Exosomes: vesicular carriers for intercellular communication. Curr Opin Cell Biol 21:575–581. CrossRef Medline
39. Simpson RJ, Jensen SS, Lim JW. (2008) Proteomic profiling of exosomes: Current perspectives. Proteomics 8:4083–4099. CrossRef Medline
40. Tamai K, Toyoshima M, Tanaka N, Yamamoto N, Owada Y, Kiyonari H, Murata K, Ueno Y, Ono M, Shimosegawa T, Yaegashi N, Watanabe M, Sugamura K (2008) Loss of hrs in the central nervous system causes accumulation of ubiquitinated proteins and neurodegeneration. Am J Pathol 173:1806–1817. CrossRef Medline
41. Tamai K, Tanaka N, Nakano T, Kakazu E, Kondo Y, Inoue J, Shiina M, Fukushima K, Hoshino T, Sano K, Ueno Y, Shimosegawa T, Sugamura K (2010) Exosome secretion of dendritic cells is regulated by hrs, an ESCRT-0 protein. Biochem Biophys Res Commun 399:384–390. CrossRef Medline
42. Tan J, Zhang T, Jiang L, Chi J, Hu D, Pan Q, Wang D, Zhang Z (2011) Regulation of intracellular manganese homeostasis by Kufor–Rakeb syndrome-associated ATP13A2 protein. J Biol Chem 286:29654–29662. CrossRef Medline
43. Thuma F, Zoller M (2014) Outsmart tumor exosomes to steal the cancer initiating cell its niche. Semin Cancer Biol 28C:39–50. Medline
44. Tokuda T, Salem SA, Allsop D, Mizuno T, Nakagawa M, Qureshi MM, Locascio JJ, Schlossmacher MG, El-Agnaf OM (2006) Decreased alphasynuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease. Biochem Biophys Res Commun 349:162–166. CrossRef Medline
45. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Bru¨gger B, Simons M (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:1244–1247. CrossRef Medline
46. Tsunemi T, Krainc D (2014) Zn2 α-dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation. Hum Mol Genet 23:2791–2801. CrossRef Medline
47. Tsunemi T, Ashe TD, Morrison BE, Soriano KR, Au J, Roque RA, Lazarowski ER, Damian VA, Masliah E, La Spada AR (2012) PGC-1alpha rescues Huntington’s disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med 4:142ra97. CrossRef Medline
48. Usenovic M, Tresse E, Mazzulli JR, Taylor JP, Krainc D (2012a) Deficiency of ATP13A2 leads to lysosomal dysfunction, alpha-synuclein accumulation, and neurotoxicity. J Neurosci 32:4240–4246. CrossRef Medline
49. Usenovic M, Knight AL, Ray A, Wong V, Brown KR, Caldwell GA, Caldwell KA, Stagljar I, Krainc D (2012b) Identification of novel ATP13A2 interactors and their role in alpha-synuclein misfolding and toxicity.HumMol Genet 21:3785–3794. CrossRef Medline